Fig. 2From: Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysisKaplan–Meier analysis of progression-free survival (PFS)Back to article page